TY - CHAP
T1 - Molecular imaging in oncology
AU - Lopci, Egesta
AU - Fanti, Stefano
PY - 2013
Y1 - 2013
N2 - The major application for PET imaging in clinical practice is represented by cancer imaging and 18F-FDG is the most widely employed positron emitter compound. However, some diseases cannot be properly evaluated with this tracer and thus there is the necessity to develop more specific compounds. The last decades were a continuous factory for new radiopharmaceuticals leading to an endless list of PET tracers; however, just some of them guard diagnostic relevance in routine medical practice. This chapter describes a selected list of non-FDG PET tracers, basing on their introduction into and impact on clinical practice.
AB - The major application for PET imaging in clinical practice is represented by cancer imaging and 18F-FDG is the most widely employed positron emitter compound. However, some diseases cannot be properly evaluated with this tracer and thus there is the necessity to develop more specific compounds. The last decades were a continuous factory for new radiopharmaceuticals leading to an endless list of PET tracers; however, just some of them guard diagnostic relevance in routine medical practice. This chapter describes a selected list of non-FDG PET tracers, basing on their introduction into and impact on clinical practice.
UR - http://www.scopus.com/inward/record.url?scp=84871830741&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871830741&partnerID=8YFLogxK
U2 - 10.1007/978-3-642-10853-2-13
DO - 10.1007/978-3-642-10853-2-13
M3 - Chapter
C2 - 23179889
AN - SCOPUS:84871830741
SN - 9783642108525
VL - 187
T3 - Recent Results in Cancer Research
SP - 371
EP - 400
BT - Recent Results in Cancer Research
ER -